1. Home
  2. LEGN vs WRBY Comparison

LEGN vs WRBY Comparison

Compare LEGN & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LEGN

Legend Biotech Corporation

SELL

Current Price

$19.87

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

SELL

Current Price

$24.97

Market Cap

3.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LEGN
WRBY
Founded
2014
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
LEGN
WRBY
Price
$19.87
$24.97
Analyst Decision
Buy
Buy
Analyst Count
13
14
Target Price
★ $45.62
$30.46
AVG Volume (30 Days)
2.0M
★ 3.2M
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 105.88
EPS
N/A
★ 0.06
Revenue
N/A
★ $871,905,000.00
Revenue This Year
$39.73
$11.38
Revenue Next Year
$23.42
$17.05
P/E Ratio
★ N/A
$413.92
Revenue Growth
N/A
★ 13.04
52 Week Low
$16.24
$14.96
52 Week High
$37.50
$31.00

Technical Indicators

Market Signals
Indicator
LEGN
WRBY
Relative Strength Index (RSI) 55.45 45.52
Support Level $19.71 $23.86
Resistance Level $19.92 $26.40
Average True Range (ATR) 0.82 1.39
MACD 0.14 -0.13
Stochastic Oscillator 92.40 10.99

Price Performance

Historical Comparison
LEGN
WRBY

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: